European Market for Non-Invasive Blood Pressure Monitoring

The European market for non-invasive blood pressure monitoring is witnessing steady growth as a result of improving awareness of the health risks of high blood pressure (BP). These are the latest findings from Frost & Sullivan (Palo Alto, CA, USA), an international consulting firm.

There is now a greater acknowledgement of the need to be vigilant against abnormal BP levels, increasing the practice of self-monitoring among the general public. As a result, market participants need to provide efficient sphygmomanometers at lower prices for home use. However, this increased demand is a double-edged sword; while prices of aneroid and digital sphygmomanometers in Europe have dropped due to the increasing presence of sphygmomanometers imported from Chinese or Korean manufacturers, the increased competition has not only impacted on profitability, but also on the intentions of market participants to invest in research and development in order to bring about product innovation. A symbiotic relationship between the established companies and new market participants will help in cutting cost and increasing the market share of the companies.

"Thanks to educational programs and general physician advice, people are making a move towards preventive healthcare to avoid the consequences of hypertension,” said Frost & Sullivan research analyst Akanksha Joshi. "This trend is making blood pressure a household concern, hence providing ample opportunities in the home care market for blood pressure monitoring.”

"Furthermore, environmental issues relating to use of mercury in measuring devices has led to its ban in many European countries, impacting the market share of mercury sphygmomanometers,” added Ms. Joshi. "Given this, companies need to focus on developing accurate blood pressure monitors that can surpass mercury sphygmomanometers as the standard.”

Among the product segments, sphygmomanometers account for the maximum revenues, followed by automated blood pressure monitors and ambulatory blood pressure monitors. The sphygmomanometers market is forecast to grow at a compound annual rate of 8.8% between 2007 and 2014, with market revenues for aneroid and digital sphygmomanometers increasing considerably. Frost & Sullivan has found that the European non-invasive BP monitors market earned revenues of over US$252 million in 2007 and estimates this to reach $444 million in 2014.


Related Links:
Frost & Sullivan